Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EMR | Common Stock | Award | +22.8K | +134.05% | 39.8K | Nov 6, 2023 | Direct | F1, F2 | ||
transaction | EMR | Common Stock | Award | +29.2K | +73.47% | 69K | Nov 6, 2023 | Direct | F3, F4 | ||
holding | EMR | Common Stock | 87K | Nov 6, 2023 | By Trust | ||||||
holding | EMR | Common Stock | 1.39K | Nov 6, 2023 | 401(k) plan | ||||||
holding | EMR | Common Stock | 491 | Nov 6, 2023 | Profit Sharing Plan |
Id | Content |
---|---|
F1 | Acquisition of 22,788 shares pursuant to Rule 16b-3 upon payout of 41,434 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2023. Of these 41,434 units, 22,788 units were paid in shares of Issuer stock, with the remaining 18,646 units paid in cash to cover the reporting person's tax obligations. |
F2 | Price is not applicable to the acquisitions described in Note 1. |
F3 | Grant to Reporting Person of 29,232 restricted stock units under shareholder approved benefit plan pursuant to Rule 16b-3(d). |
F4 | Price is not applicable to acquisitions resulting from grants of restricted stock units. |